Remodelling of extracellular matrix (ECM) differs between tumor centre and invasion front in human non-small cell lung cancer: immunohistochemistry and morphometry of matrix proteins (MP), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (T

E. Herpel, C. Schopf, A. Warth, F. J. F. Herth, P. A. Schnabel, P. Schirmacher, H. Hoffmann, M. Thomas, D. Kieslich de Hol (Heidelberg, Germany)

Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases

Session: Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Session type: E-Communication Session
Number: 396

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Herpel, C. Schopf, A. Warth, F. J. F. Herth, P. A. Schnabel, P. Schirmacher, H. Hoffmann, M. Thomas, D. Kieslich de Hol (Heidelberg, Germany). Remodelling of extracellular matrix (ECM) differs between tumor centre and invasion front in human non-small cell lung cancer: immunohistochemistry and morphometry of matrix proteins (MP), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (T. Eur Respir J 2008; 32: Suppl. 52, 396

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Remodelling of extracellular matrix (ECM) differs between pulmonary adenocarcinoma (Ad) and squamous cell carcinoma (Sq): immunohistochemistry and morphometry of matrix proteins (MPs), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008
Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018
Effects of keratinocyte growth factor (KGF) on matrix metalloproteinases (MMPs) & tissue inhibitors of metalloproteinases (TIMPs) mRNA levels in emphysematous rats lungs Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008
Quantitative assessment of matrix metalloproteinasis 7 (MMP-7) and tissue inhibitor of MMP-7 (TIMP1) in NSCLC tissue samples Source: Eur Respir J 2006; 28: Suppl. 50, 813s Year: 2006
Statins inhibit matrix metalloproteinase release from human lung fibroblasts Source: Eur Respir J 2010; 35: 637-646 Year: 2010
Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2007; 30: Suppl. 51, 137s Year: 2007
Biological role of matrix metalloproteinases: a critical balance Source: Eur Respir J 2011; 37: 191-208 Year: 2011
Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
Metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor (TGFβ) in pleural tuberculosis Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Effects of cyclic stretch on stiffness and matrix metalloproteinases (MMPs) in mouse lung tissue strips Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009
Effects of steroids and b-mimetics on matrix metalloproteinases expression in human lung primary cells Source: Eur Respir J 2003; 22: Suppl. 45, 453s Year: 2003
The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation Source: Eur Respir J 2009; 33: 134-141 Year: 2009
Expression of matrix metalloproteinases (MMPs) in primary spontaneous pneumothorax: MMP-9 as a potential biomarker for surgical intervention Source: International Congress 2017 – Thoracic surgery Year: 2017
Circulating matrix metalloproteinase-9 (MMP-9) is associated with the extension of lung disease in patients with active tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 35s Year: 2004
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF Source: Eur Respir J 2002; 20: 1220-1227 Year: 2002
Matrix metalloproteinases in tuberculosis Source: Eur Respir J 2011; 38: 456-464 Year: 2011
A therapeutic role for matrix metalloproteinase inhibitors in lung diseases? Source: Eur Respir J 2011; 38: 1200-1214 Year: 2011
A role of matrix metalloproteinases and their inhibitors in the pathogenesis of fibrosis and angiogenesis in lung precancer processes Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010